|
The
dosage of the antipyretics used in
this trial was as follows:
|
AEKNIL |
- |
2 mg/kg (Body wgt. Below
10 kg.) |
| |
- |
3 mg/kg (Body wgt. Below
10 kg.) |
Dosage was same
for both Oral and Injectable forms.
It was administered in two divided
doses daily.
A.P.C Powder
- 2 mg/kg. Body wgt.
Mist Diaphoretic
- dr.1 per year of age.
A.P.C and Mist
Diaphoretic were administered orally
in three divided doses daily.
The
nature of the cases studied has been
tabulated below:
|
(A) Diagnosis |
U.R.T.I |
Febrile Convulsions |
Bronchiolitis
Broncho-pneumonis |
P.U.O |
Meningitis + Encephalitis |
Miscellaneous |
Total |
|
AEKNIL |
48 |
4 |
10 |
40 |
8 |
10 |
120 |
|
A.P.C |
42 |
6 |
14 |
36 |
10 |
12 |
120 |
|
Mist. Diaphoretic |
40 |
8 |
12 |
32 |
12 |
16 |
120 |
|
U.R.T.I |
Upper Respiratory tract
Infection |
|
P.U.O |
Pyrexia of Unknown
Origin |
Miscellaneous group included
“Primary Complex”, Gastroenteritis,
Hepatitis, Cirrhosis, Poliomyelitis,
Leukemia etc.
|
